Kera Capital Partners Inc. bought a new stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 2,409 shares of the company’s stock, valued at approximately $219,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. XTX Topco Ltd purchased a new position in Colgate-Palmolive during the second quarter valued at approximately $423,000. Ieq Capital LLC boosted its holdings in Colgate-Palmolive by 22.6% in the 2nd quarter. Ieq Capital LLC now owns 38,617 shares of the company’s stock valued at $3,747,000 after purchasing an additional 7,130 shares during the period. AE Wealth Management LLC grew its position in shares of Colgate-Palmolive by 70.9% during the 2nd quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock valued at $2,194,000 after purchasing an additional 9,382 shares in the last quarter. Sei Investments Co. increased its holdings in shares of Colgate-Palmolive by 1.8% in the second quarter. Sei Investments Co. now owns 609,139 shares of the company’s stock worth $59,111,000 after purchasing an additional 10,500 shares during the period. Finally, Summit Trail Advisors LLC raised its position in shares of Colgate-Palmolive by 2.6% in the second quarter. Summit Trail Advisors LLC now owns 5,490 shares of the company’s stock worth $533,000 after buying an additional 141 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Up 0.3 %
Shares of NYSE CL opened at $88.79 on Monday. The firm’s fifty day moving average is $92.20 and its 200 day moving average is $97.75. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
Wall Street Analyst Weigh In
CL has been the topic of a number of research analyst reports. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $101.11.
Get Our Latest Stock Analysis on CL
Insider Transactions at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.34% of the stock is currently owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Stock Sentiment Analysis: How it Works
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Manufacturing Stocks Investing
- Oilfield Leader SLB: An AI Name You Need to Know
- What Are Earnings Reports?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.